It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
(visit the link for the full news article)
The US Food and Drug Administration (FDA) has approved a new weight-loss drug from the pharmaceutical company Vivus.
The FDA approved Qsymia for patients who are overweight or obese and have at least one other weight-related condition.
The approval comes after the FDA gave another anti-obesity drug, Belviq, the green light last month.
The approvals are the first in the US for 13 years.